{
    "root": "eb93bf1e-9a04-48ff-9ed7-94473bcd5552",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "ondansetron",
    "value": "20250505",
    "ingredients": [
        {
            "name": "ONDANSETRON HYDROCHLORIDE",
            "code": "NMH84OZK2B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7774"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "ondansetron tablets indicated prevention nausea vomiting associated : highly emetogenic cancer chemotherapy , including cisplatin greater equal 50 mg/m2 . initial repeat courses moderately emetogenic cancer chemotherapy . radiotherapy patients receiving either total body irradiation , single high-dose fraction abdomen , daily fractions abdomen ondansetron tablets also indicated prevention postoperative nausea and/or vomiting .",
        "doid_entities": [
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "full prescribing information recommended adults pediatrics ( 2 ) patients severe hepatic impairment : exceed total daily dose 8 mg ( 2.2 , 8.6 )",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe hepatic impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "ondansetron tablets ondansetron tablets ondansetron tablets usp , 4 mg ( ondansetron hydrochloride usp , equivalent 4 mg ondansetron ) white , round , biconvex , film coated tablets debossed \u201c r \u201d one side \u201c 153 \u201d side supplied : overbagged 10 film coated tablets per bag , ndc 55154-3551-0 ondansetron tablets usp , 8 mg ( ondansetron hydrochloride usp , equivalent 8 mg ondansetron ) yellow , round , biconvex , film coated tablets debossed \u201c r \u201d one side \u201c 154 \u201d side supplied : overbagged 10 film coated tablets per bag , ndc 55154-7879-0 warning : unit dose packages child resistant intended institutional . keep drugs reach children . store 20\u00b0-25\u00b0c ( 68\u00b0-77\u00b0f ) ( usp controlled room temperature ) . dispense tight container defined usp . store blisters cartons .",
    "adverseReactions": "ondansetron contraindicated patients : \u2022known hypersensitivity ( e.g . , anaphylaxis ) ondansetron components formulation [ ( 6.2 ) ] \u2022receiving concomitant apomorphine due risk profound hypotension loss consciousness",
    "indications_original": "Ondansetron\u00a0\u00a0tablets are indicated for the prevention of nausea and vomiting associated with: \n                  \n                     \n                        \u00a0highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2 .\n                     \n                        \u00a0 initial and repeat courses of moderately emetogenic cancer chemotherapy.\n                     \n                        \u00a0radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen\n                  \n                  Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting.",
    "contraindications_original": "See full prescribing information for the recommended dosage in adults and pediatrics (2) Patients with severe hepatic impairment: do not exceed a total daily dose of 8 mg ( 2.2 , 8.6 )",
    "warningsAndPrecautions_original": "Ondansetron Tablets\n                  \n                  Ondansetron Tablets Ondansetron tablets USP, 4 mg (ondansetron hydrochloride USP, equivalent to 4 mg of ondansetron) are white, round, biconvex, film coated tablets debossed \u201cR\u201d on one side and \u201c153\u201d on other side and are supplied:\n                  Overbagged with 10 film coated tablets per bag,\u00a0NDC 55154-3551-0\n                  Ondansetron tablets USP, 8 mg (ondansetron hydrochloride USP, equivalent to 8 mg of ondansetron) are yellow, round, biconvex, film coated tablets debossed \u201cR\u201d on one side and \u201c154\u201d on other side and are supplied:\n                  Overbagged with 10 film coated tablets per bag,\u00a0NDC 55154-7879-0\n                  WARNING: These Unit Dose packages are not child resistant and are Intended for Institutional Use Only. Keep this and all drugs out of the reach of children.\n                  Store at 20\u00b0-25\u00b0C (68\u00b0-77\u00b0F) (See USP Controlled Room Temperature). Dispense in tight container as defined in the USP. Store blisters in cartons.",
    "adverseReactions_original": "Ondansetron is contraindicated in patients: \n                  \n                     \n                        \u2022known to have hypersensitivity (e.g., anaphylaxis) to ondansetron or any of the components of the formulation [see Adverse Reactions (6.2)]\n                     \n                     \n                        \u2022receiving concomitant apomorphine due to the risk of profound hypotension and loss of consciousness",
    "drug": [
        {
            "name": "ondansetron",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7773"
        }
    ]
}